MIR3159

Across TCGA pan-cancer cohorts, MIR3159 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR3159 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR3159 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3159 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

UCS, OV, and LIHC are the cancer types where MIR3159 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
OV	OS	Tertile	All	0.918	0.672	.003	90	view →
LIHC	OS	Tertile	III,IV	0.051	0.738	<.001	48	view →
COAD	OS	Tertile	All	0.381	0.805	.001	36	view →
ESCA	OS	Tertile	All	0.471	0.906	.031	18	view →
READ	DFS	Tertile	All	0.111	0.799	.001	18	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR3159–UCS (DFS)

Open the UCS breakdown →